Webinar: The PERIO-02 Trial – Enabling Immunotherapy for Intrahepatic Cholangiocarcinoma
Webinar: The PERIO-02 Trial – Enabling Immunotherapy for Intrahepatic Cholangiocarcinoma
On Thursday, January 13, 2022, at 4:00pm ET, Steven C. Katz, Chief Medical Officer at TriSalus Life Sciences, will host a webinar to discuss the Pressure-Enabled Regional Immuno-Oncology (PERIO-02) clinical trial for adults with intrahepatic cholangiocarcinoma and hepatocellular carcinoma, the most common liver tumors. Learn more or join here.